Liu Shi Xin

Baru
40 tahun pengalaman
Lokasi: China, Xiamen
Klinik:Rumah Sakit Xiamen Humanity
Professor Shixin Liu, MD, PhD, is the Discipline Leader of the Oncology Center. He is the former President of Jilin Provincial Cancer Hospital and former Director of the Cancer Prevention and Treatment Research Institute. He is a second-level professor and doctoral supervisor. He has received the State Council Special Government Allowance, the 4th National Famous Doctor (Outstanding Contribution) award, and the Model of Medical Ethics honor.

He specializes in the comprehensive diagnosis and treatment of malignant tumors. His focus is precision radiotherapy for thoracic and abdominal cancers. He is skilled in IMRT, VMAT, and SBRT for lung, esophageal, breast, and rectal cancers.

His leadership roles include Vice Chair of CMA Radiation Oncology, CACA Radiotherapy, and CACA Particle Therapy. He serves on the CSCO Standing Committee and as Vice Chair of the CSCO Radiation Oncology Expert Committee. He is Vice Chair of CPAM Radiation Oncology and a Standing Committee member of CSMEA. He chairs the Jilin Medical Association Radiation Oncology branch. He is on the editorial boards of the Chinese Journal of Radiation Oncology and the Practical Journal of Cancer.
Baca selengkapnya

Baru

Kunjungan dokter

Harga berdasarkan permintaan

Bookimed Insights: Spesialis Kanker paru-paru Teratas di China (2026)

Bookimed telah mengoordinasikan 1 permintaan perawatan Kanker paru-paru di China, bekerja sama dengan 1 spesialis berperingkat tinggi. Dokter pada tabel ini dipilih berdasarkan kredensial internasional, keahlian klinis, dan hasil pasien. Peringkat 2026 disusun menggunakan data terverifikasi dari kasus pasien aktual dan program klinik mitra saat ini.

Peringkat	Dokter	pengalaman	Cocok Untuk	Apa yang Membedakan Mereka	Klinik & Lokasi	Konsultasi

FAQ

FAQ ini berasal dari pasien nyata yang mencari bantuan medis melalui Bookimed. Jawaban diberikan oleh koordinator medis berpengalaman dan perwakilan klinik terpercaya.

Is lung cancer treatment in China of high quality for international patients?

China provides high-quality lung cancer care through specialized oncology centers in Guangzhou, Shanghai, and Beijing. These JCI-accredited facilities offer advanced technologies like CyberKnife M6 and NanoKnife. High patient volumes allow surgeons to achieve remarkable procedural mastery in minimally invasive thoracic surgeries.

Advanced technology: Facilities use CyberKnife M6 and proton-beam therapy for tumors.
Specialized therapies: Clinics offer NanoKnife, cryosurgery, and vascular interventional therapy.
Surgical expertise: Dr. Niu Lizhi has performed nearly 10,000 successful cryosurgery procedures.
Rapid diagnostics: Centers combine PET-CT, genomic sequencing, and tumor markers for staging.

Bookimed Expert Insight: High-volume centers like Fuda Cancer Hospital treat 30,000+ international patients yearly. This massive data pool helps specialists refine protocols for advanced stages. Dr. Liuying at Jinshazhou Hospital even contributed to national expert consensus on lung tumor ablation. This level of specialization ensures that doctors see more complex cases in one month than many Western surgeons see in a year.

Patient Consensus: Patients note that top-tier care often rivals Western standards, especially for targeted therapies. They recommend hiring a private Mandarin translator and utilizing VIP departments to navigate language barriers effectively.

What advanced lung-cancer therapies are available in China?

Advanced lung cancer therapies in China center on next-generation immunotherapy and high-precision minimally invasive procedures. Facilities utilize domestic breakthroughs like Ivonescimab alongside international standards. Molecularly targeted drugs for EGFR and ALK mutations are widely available. Treatment often integrates CyberKnife M6 radiosurgery and specialized cryosurgical ablation.

Targeted therapy: Broad access to domestic TKIs like Aumolertinib and Furmonertinib for EGFR mutations.
Immunotherapy: Novel monoclonal antibodies including Camrelizumab and Tislelizumab are standard first-line options.
Minimally invasive: Facilities provide cryosurgery, NanoKnife ablation, and radiofrequency ablation for localized tumor control.
Advanced radiation: CyberKnife M6 systems deliver precise radiosurgery for complex cases in oncology centers.

Bookimed Expert Insight: A major advantage for lung cancer patients in China is the massive scale of specialized centers. Dr. Niu Lizhi at Fuda Cancer Hospital has performed over 10,000 cryosurgeries. This high volume often translates to expertise in treating late-stage cancers. Patients can access specific technologies like NanoKnife that are less common in standard European or North American protocols.

Patient Consensus: Patients value the speed of enrollment for clinical trials and the affordability of genomic testing. Many suggest using official hospital mobile apps for scheduling to streamline care during their stay.

Which hospitals are internationally recommended for lung-cancer treatment in China?

Top-tier Chinese hospitals for lung cancer treatment include JCI-accredited centers like Fuda Cancer Hospital and the Cancer Hospital of the Chinese Academy of Medical Sciences. These institutions offer advanced therapies such as cryosurgery, NanoKnife, and CyberKnife M6. They follow international NCCN guidelines while processing high patient volumes.

Fuda Cancer Hospital: JCI-accredited facility in Guangzhou specializing in minimally invasive treatments for advanced stage cases.
Jinshazhou Hospital: Offers CyberKnife M6 stereotactic radiosurgery and standardized microwave ablation for targeted tumor destruction.
Specialized surgical volumes: National centers in Beijing and Shanghai perform thousands of thoracic surgeries annually.
International patient services: Selected hospitals provide dedicated translation and coordinators for over 100 countries.

Bookimed Expert Insight: While high-profile national centers in Beijing handle massive volumes, private JCI-accredited hospitals like Fuda Cancer Hospital offer a significant coordination advantage. Dr. Niu Lizhi at Fuda has performed nearly 10,000 cryosurgeries. This specific procedural experience often exceeds that of western specialists. Choosing a clinic with such high individual doctor case numbers can lead to better precision in complex, minimally invasive lung procedures.

Patient Consensus: Patients note that while medical technology is advanced, having a professional coordinator is vital for navigating language barriers. Many emphasize that the high surgical volume translates to very experienced thoracic teams and modern immunotherapy options.

How do international patients overcome language barriers and manage logistics?

International patients manage lung cancer treatment in China through dedicated international departments providing on-site interpreters and logistical support. Facilities like Fuda Cancer Hospital serve over 30,000 global patients. Specialized coordinators handle medical visa invitations, airport transfers, and local housing to ensure seamless clinical transitions.

Professional interpretation: Experts handle nuanced discussions for therapies like NanoKnife or CyberKnife M6.
Coordinated logistics: International desks arrange travel, visa extensions, and halal or kosher meals.
Bundled packages: Packages often include consultations, medications, transfers, and hospitalization for streamlined care.
Digital support: Clinics provide SIM cards with translation apps and WeChat group communication.

Bookimed Expert Insight: While many think Tier-1 cities are the only option, Guangzhou has emerged as a specialized hub for lung cancer. Fuda Cancer Hospital and Jinshazhou Hospital offer advanced technologies like Cryosurgery and CyberKnife M6. These centers prioritize international patients, with surgeons like Dr. Niu Lizhi having performed nearly 10,000 cryosurgeries.

Patient Consensus: Patients emphasize that hiring a private medical interpreter is essential for accurate dosing. They also suggest joining digital expat networks to navigate mobile payments and high-speed rail travel successfully.

Can I secure a remote second opinion before traveling to China?

International patients can secure remote second opinions for lung cancer treatment in China through virtual consultations or written reports. Leading facilities in Guangzhou and Shanghai use telemedicine to review pathology slides and CT scans. This process establishes treatment protocols and provides cost clarity before patients commit to international travel.

Consultation methods: Patients access specialists via video calls, text-based reviews, or formal written reports.
Required documentation: Experts require digital pathology reports, CT/MRI imaging, and biomarker testing results (EGFR/ALK).
Turnaround time: Most international departments deliver a formal specialist opinion within 7 to 14 days.
Advanced technologies: Reviews may include suitability for CyberKnife M6, NanoKnife, or cryosurgery for late-stage cases.

Bookimed Expert Insight: Bookimed data shows that packages for advanced therapies, such as the CyberKnife M6 at Jinshazhou Hospital, often include the initial video or text consultation as a standard service. This allows patients to confirm the technical feasibility of stereotactic radiosurgery before arrival. Dr. Zhang Yanjun and other specialists at this facility integrate these remote screenings to ensure the 56,000 CNY treatment cost is medically justified for the specific tumor stage.

Patient Consensus: Patients emphasize that sharing digital pathology slides is essential for accurate remote reviews. Many note that high-volume centers like Fuda Cancer Hospital provide preliminary assessments via digital channels to help clarify complex cases early.

Kanker paru-paru Dokter Terbaik di Xiamen - TOP-1 dokter

Dapatkan penawaran dari 3 spesialis teratas di China